Savara Inc (SVRA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.02B
Last updated: Nov 17, 2026 at 4:40 PM ET
Savara Inc (SVRA) Statistics
Savara (SVRA) has a market cap of $1.02B and an enterprise value of $1.02B. Revenue fell 100.00% over the last 12 months from the 12 months before. Its share count is up 17.44% from a year earlier.
Total Valuation
Enterprise value is 0.05% above the market cap, as debt exceeds cash.
| Market Cap | $1.02B |
|---|---|
| Enterprise Value | $1.02B |
| Latest price (Nov 17, 2026) | $4.48 |
Key Dates
The next earnings report is expected on Mar 11, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 11, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Valuation Ratios
| Forward P/S | 761.4x |
|---|---|
| P/B Ratio | 10.6x |
| P/TBV Ratio | 11.8x |
Price Statistics
The stock is up 4.19% over 52 weeks and trades 8.57% below its 50-day average.
| Beta (1Y) | 1.40 |
|---|---|
| 52-Week Change | +4.19% |
| 1-Month Change | -3.24% |
| 3-Month Change | -19.71% |
| 6-Month Change | -5.08% |
| 5-Year Change | +315.52% |
| 10-Year Change | -10.13% |
| Total Return (1Y) | +4.19% |
| Total Return (3Y CAGR) | +6.30% |
| Total Return (5Y CAGR) | +32.45% |
| Return vs SPY (1Y) | -4.13% |
| Max Drawdown (1Y) | -39.19% |
| Max Drawdown (3Y) | -65.30% |
| Sharpe Ratio (1Y) | 0.13 |
| Correlation with SPY (1Y) | 0.36 |
| 50-Day Average | $4.90 |
| 200-Day Average | $5.32 |
| 52-Week Range | $4.13 to $7.00 |
| RSI (14 Days) | 42.8 |
| Average Volume (20 Days) | 2.98M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 8.55x current liabilities, and total debt is 0.28x shareholder equity.
| Current Ratio | 8.55x |
|---|---|
| Quick Ratio | 8.55x |
| Debt / Equity | 0.28x |
Returns and Efficiency
Return on invested capital is -87.30% over the last 12 months, against a 5-year average of -33.55%.
| Return on Equity (ROE) | -141.62% |
|---|---|
| Return on Assets (ROA) | -97.95% |
| Return on Invested Capital (ROIC) | -87.30% |
| Return on Capital Employed (ROCE) | -109.64% |
| ROE (5Y Average) | -43.71% |
| ROA (5Y Average) | -34.88% |
| ROIC (5Y Average) | -33.55% |
| Receivables Turnover | 0.00x |
Scores
SVRA has an Altman Z-Score of 5.40, in the safe zone above 2.99, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 5.40 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Operating Income | -$156.93M |
| Pretax Income | -$152.74M |
| Net Income | -$152.74M |
| EBITDA | -$152.48M |
| EBIT | -$152.74M |
| Reported EPS (TTM) | -$0.61 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 69.17% of the $155.93M in total assets.
| Cash and Equivalents | $29.81M |
|---|---|
| Total Debt | $30.36M |
| Net Debt | $551.00K |
| Net Debt Per Share | $0.00 |
| Working Capital | $125.49M |
| Shareholder Equity | $107.85M |
| Book Value Per Share | $0.42 |
| Tangible Book Value | $96.60M |
| Tangible Book Per Share | $0.38 |
| Total Assets | $155.93M |
| Total Liabilities | $48.08M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $631.00K of capital spending, operating cash flow left -$130.94M of free cash flow.
| Operating Cash Flow | -$130.31M |
|---|---|
| Capital Expenditures | $631.00K |
| Free Cash Flow | -$130.94M |
| FCF Per Share | -$0.59 |
| Depreciation and Amortization | $261.00K |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | +8.18% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | +9.39% |
Dividends and Yields
SVRA does not pay a dividend. Its free cash flow yield is -11.50%.
| FCF Yield | -11.50% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-70 reverse split on Apr 28, 2017.
| Last Split Date | Apr 28, 2017 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:70 |
Peer Position
Against 5 similar companies, SVRA has the 4th highest ROIC.
ROICPeer median -65.05%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +10.68%
| ROIC | -87.30% vs -65.05% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -100.00% vs +10.68% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About SVRA
What is SVRA's market cap?
Savara has a market cap of $1.02B. Its enterprise value, which adds debt and subtracts cash, is $1.02B.
How many shares of SVRA are outstanding?
Savara has 254.22M shares outstanding. The count is up 17.44% from a year earlier.
Does SVRA pay a dividend?
No. Savara does not pay a dividend.
How much debt does SVRA have?
Savara has $30.36M of total debt and $29.81M of cash and equivalents, a net debt position of $551.00K.
SVRA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors